Evidence map›Paper›PMID 40118898›Full record

ArticleScientific reports2025

Data collaboration for causal inference from limited medical testing and medication data.

Tomoru Nakayama, Yuji Kawamata, Akihiro Toyoda, Akira Imakura, Rina Kagawa, Masaru Sanuki, Ryoya Tsunoda, Kunihiro Yamagata, Tetsuya Sakurai, Yukihiko Okada

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomoru NakayamaGraduate School of Science and Technology, University of Tsukuba, Tsukuba, Japan.
Yuji KawamataCenter for Artificial Intelligence Research, University of Tsukuba, Tsukuba, Japan. yjkawamata@gmail.com.
Akihiro ToyodaGraduate School of Science and Technology, University of Tsukuba, Tsukuba, Japan.
Akira ImakuraCenter for Artificial Intelligence Research, University of Tsukuba, Tsukuba, Japan.
Rina KagawaArtificial Intelligence Research Center, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan.
Masaru SanukiFaculty of Medicine, Department of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
Ryoya TsunodaFaculty of Medicine, Department of Nephrology, University of Tsukuba, Tsukuba, Japan.
Kunihiro YamagataFaculty of Medicine, Department of Nephrology, University of Tsukuba, Tsukuba, Japan.
Tetsuya SakuraiCenter for Artificial Intelligence Research, University of Tsukuba, Tsukuba, Japan.
Yukihiko OkadaCenter for Artificial Intelligence Research, University of Tsukuba, Tsukuba, Japan.

Funding

Cross-ministerial Strategic Innovation Promotion Program JPJ012425Japan Science and Technology Agency JPMJPF2017Japan Science and Technology Agency JPMJPR23I3Japan Society for the Promotion of Science JP23H03502
6 · The paper itself

Abstract

Observational studies enable causal inferences when randomized controlled trials (RCTs) are not feasible. However, integrating sensitive medical data across multiple institutions introduces significant privacy challenges. The data collaboration quasi-experiment (DC-QE) framework addresses these concerns by sharing "intermediate representations"-dimensionality-reduced data derived from raw data-instead of the raw data. Although DC-QE can estimate treatment effects, its application to medical data remains unexplored. The aim of this study was to apply the DC-QE framework to medical data from a single institution to simulate distributed data environments under independent and identically distributed (IID) and non-IID conditions. We propose a method for generating intermediate representations within the DC-QE framework. Experimental results show that DC-QE consistently outperformed individual analyses across various accuracy metrics, closely approximating the performance of centralized analysis. The proposed method further improved performance, particularly under non-IID conditions. These outcomes highlight the potential of the DC-QE framework as a robust approach for privacy-preserving causal inferences in healthcare. Broader adoption of this framework and increased use of intermediate representations could grant researchers access to larger, more diverse datasets while safeguarding patient confidentiality. This approach may ultimately aid in identifying previously unrecognized causal relationships, support drug repurposing efforts, and enhance therapeutic interventions for rare diseases.

Indexed as

CausalityHumansObservational Studies as TopicData collaboration frameworkDistributed dataPrivacy-preserving causal inferencePropensity score matching

Identifiers

PMID40118898
PMCPMC11928589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.